154
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

New study shows that extending prophylaxis with Clexane® (enoxaparin sodium injection) to five weeks is more effective than 10 days for reducing the risk of Venous Thromboembolism (VTE) in acutely ill medical patients with reduced mobility

EXCLAIM is the first international study to show that extended thromboprophylaxis reduces VTE risk in acutely-ill medical patients with a statistically significant 44%

Reprints and Permissions

Taylor & Francis does not sell reprints or permissions for this article. Please refer to the 'Licensing' tab on the article menu bar for information on the reuse conditions associated with this license type.